Slide 1: Interim Report April – June 2025
Interim Report April – June 2025 22August 2025 Sleep Cycle © 2025 Sl eep Cycle AB. All Rights Reserv ed 1
Slide 2: Presenters
Presenters Erik Jivmark Elisabeth Hedman Chief Executive Officer Chief Finance Officer & Head of Investor Relations Sleep Cycle © 2025 Sl eep Cycle AB. All Rights Reserv ed 2
Slide 3: Our Mission
Our Mission is to improve global health by empowering people to take control of their sleep. Sleep Cycle © 2025 Sl eep Cycle AB. All Rights Reserv ed 3
Slide 4: We Unlock Healthy Habits
We Unlock Healthy Habits Xd We transform sleep habits by providing powerful tools and features to improve sleep quality and offering deep insights into sleep patterns, ultimately leading to a more satisfying life. Sleep Cycle © 2025 Sl eep Cycle AB. All Rights Reserv ed 4
Slide 5: Our Strategy
Our Strategy User Acquisition User Engagement Platform and Data Improve the upper funnel Product development Monetization of data and technology Installs Conversion Data monetization Subscriptions Retention Technology licensing ARPU New products leveraging the platform Sleep Cycle © 2025 Sl eep Cycl
Slide 6: The World's No.1 Sleep App Streams of Health Data
The World's No.1 Sleep Streams of Health Data Integrate with App Patented Technology Personalized Sleep Insights for Massive, Actionable Health Dataset Flexible SDK & Supporting Better Health R&D Capabilities With over 3 billion nights of anonymized sleep Deliver tailored, data-driven sleep insights
Slide 7: The Evolution of Healthcare
The Evolution of Healthcare Healthcare 1.0 Pre-Scientific Revolution Trial and error-based treatment, limited evidence base and efficacy. Healthcare 2.0 Today Evidence-based and effective, but reactive, treatment-focused with limited focus on prevention. Healthcare 3.0 The Future Proactive, personal
Slide 8: Solving a Public Health Problem at Scale
SLEEP APNEA Solving a Public Health Problem at Scale 950M Age 30–69 suffer from mild to severe sleep apnea worldwide 80% Of individuals with Obstructive Sleep Apnea remain undiagnosed 3x Greater risk of heart disease, stroke, and diabetes Sleep Cycle © 2025 Sl eep Cycle AB. All Rights Reserv ed 8
Slide 9: Strategic Leap into a Multi-Billion Market
SLEEP APNEA Strategic Leap into a Multi- Billion Market Expanding our Total Addressable Market (TAM) Building new high-margin revenue stream Opens doors to B2B partnerships and health markets Sleep Cycle © 2025 Sl eep Cycle AB. All Rights Reserv ed 9
Slide 10: Clinical Study Underway
SLEEP APNEA Clinical Study Underway Dr. Kågebäck Dr. Gradisar Led by Sleep Scientist Dr. Gradisar & AI expert Dr. Kågebäck Sleep Cycle © 2025 Sl eep Cycle AB. All Rights Reserv ed 10
Slide 11: Financial Development for Q2 2025
Financial Development for Q2 2025 -2.2 % -3.9 % -2.9 % 28.4 % YoY Subscriptions Growth YoY ARPU Growth YoY Net Sales Growth EBIT Margin FX Adjusted Growth -0.6% 878 K 271 SEK 64 M SEK 18 M SEK Paying Subscribers ARPU Net Sales EBIT Sleep Cycle © 2025 Sl eep Cycle AB. All Rights Reserv ed 12
Slide 12: Paying Subscribers Net Sales
Paying Subscribers Net Sales Number of paying subscribers decreased with –2.2% y-o-y to 878k, driven by Net sales decreased by –2.9% as a result of a lower intake of new customers softer market conditions leading to a lower intake of new customers. Retention combined with pressure on ARPU. FX adjust
Slide 13: EBIT Adjusted EBIT
EBIT Adjusted EBIT Continued solid profitability with an EBIT of SEK 18m and an EBIT-margin of The adjusted EBIT-margin has been above 25% for 6 quarters in a row. No NRIs 28.4% for Q2-25. in Q2-25. 33.5% 25 32.0% 32.3% 25 SEKm 33.5% 35% SEKm 31.3% 32.0% 32.3% 30.9% 31.3% 22 28.4% 30% 29.8% 22 21 21
Slide 14: Strong Margin of 28.4% in Q2-25 Despite Decrease in Net Revenue
Strong Margin of 28.4% in Q2-25 Despite Decrease in Net Revenue SEK M Q2-25 Q2-24 CHANGE COMMENTS Decline due to softer intake of new customers and a lower ARPU. FX- adjusted net sales development was -0.6%. Net sales 63.6 65.4 -2.9% Partnership generated sales was 9% of the total net sales, up from
Slide 15: Building Long-term Value in a Shifting Market
Building Long-term Valuein a Shifting Market SEK M Jan-Jun-25 Jan-Jun 24 CHANGE COMMENTS Net sales 128.5 128.9 -0.3% FX-adjusted net sales growth of +0.5% for the full period. Majority of the sales is recognized over 12 months. Capitalized work for own account 1.3 0.2 702.4% SEK 1.3m staff costs mai
Slide 16: Quarterly Highlight
Quarterly Highlight 9% Partnership revenue Powered by Sleep Apnea study Sleep Cycle Sleep Cycle © 2025 Sl eep Cycle AB. All Rights Reserv ed 17
Slide 17: Questions & Answers
Questions & Answers Sleep Cycle © 2025 Sl eep Cycle AB. All Rights Reserv ed 19